Reporter

December 6, 2018

Team spots clue to rare lung and kidney diseases

Pulmonary-renal syndrome (PRS) refers to a group of rare but potentially fatal conditions that nearly always are caused by a misguided attack by the body’s immune system on the lungs and kidneys. Coughing up blood and blood in the urine are telltale signs.

December 6, 2018

Study tests new vaccine for precancerous cervical cells

Vanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeutic vaccine for treating women with precancerous changes on the cervix.

December 6, 2018

Precision radiation aids patient’s cancer battle

After undergoing precision radiation therapy at Vanderbilt-Ingram Cancer Center, 90-year-old Imogene Stranch quickly returned to her workout routine at the Bellevue Family YMCA.

December 6, 2018

Schaffner honored by Infectious Diseases Society of America

William Schaffner, MD, professor of Preventive Medicine in the Department of Health Policy and professor of Medicine in the Division of Infectious Diseases, is the recipient of the 2018 D.A. Henderson Award for Outstanding Contributions to Public Health.

December 6, 2018

Trio of Vanderbilt scientists set for next Discovery Lecture

Three Vanderbilt scientists will discuss innovative new and ongoing programs during a Cutting-Edge Discovery Lecture on Thursday, Dec. 13. The lecture will begin at 4 p.m. in room 208 Light Hall.

December 6, 2018

Discovery could lead to neutralizing West Nile virus

Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can “neutralize” the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States.